Search by Drug Name or NDC

    NDC 00904-7166-10 Budesonide 3 mg/1 Details

    Budesonide 3 mg/1

    Budesonide is a ORAL CAPSULE, DELAYED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Major Pharmaceuticals. The primary component is BUDESONIDE.

    Product Information

    NDC 00904-7166
    Product ID 0904-7166_89fd0294-0cf9-4f9e-91d6-6771e390822b
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Budesonide
    Proprietary Name Suffix n/a
    Non-Proprietary Name Budesonide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE, DELAYED RELEASE
    Route ORAL
    Active Ingredient Strength 3
    Active Ingredient Units mg/1
    Substance Name BUDESONIDE
    Labeler Name Major Pharmaceuticals
    Pharmaceutical Class Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA206200
    Listing Certified Through 2024-12-31

    Package

    NDC 00904-7166-10 (00904716610)

    NDC Package Code 0904-7166-10
    Billing NDC 00904716610
    Package 20 BLISTER PACK in 1 CARTON (0904-7166-10) / 1 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK
    Marketing Start Date 2017-09-15
    NDC Exclude Flag N
    Pricing Information N/A